Ondansetron for intravenous use: posology in patients age 65 years or older

New advice on dilution and administration in patients age 65 years or older refers only to the indication for prevention of chemotherapy-induced nausea and vomiting.

Article date: August 2013

We would like to make you aware that on 24 July 2013 we updated the information in the recent intravenous ondansetron posology article published in the July 2013 issue of the bulletin. The article was updated to clarify that the new advice on dilution and administration in patients age 65 years or older refers only to the indication for prevention of chemotherapy-induced nausea and vomiting; there has been no change to the dosing, dilution, or administration instructions for the indication of postoperative nausea and vomiting.

If you read, downloaded, or shared the article before the update on 24 July 2013, please revisit the article to ensure that you have the most up to date information.

Article citation: Drug Safety Update vol 7 issue 1, August 2013: O3.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.